Recent Investment March 2019 II

Hey everyone, I was again able to pull the investment trigger. This time I added a couple of more shares on my existing investment of AbbVie. It is already my second investment this month, so as you can see I am really in the investment flow and I am investing aggressively at the moment. Also at the moment I see a lot of opportunities in the market in the upcoming months. 


Abbvie, Inc. (ABBV) is a maker of pharmaceutical products. Its product line includes treatments for health conditions such as rheumatoid arthritis, psoriasis, Crohn’s disease, HIV, low testosterone, thyroid disease, Parkinson’s disease, and many others. The company is headquartered in North Chicago, Illinois and was spun off from Abbott Laboratories (ABT) in January 2013.

In the end I bought 23 shares of AbbVie, which will add an additional dividend income 98.44 USD before taxes. I also finally managed to be in one of the calmer dividend months in the triple digit region.


Through this new addition my full year dividend income is now at 2 290.37 EUR or 2 596.58 USD, with a current yield of costs of 3.46%. So I finally managed it to cross my goal of 2 200 EUR annual dividend income. This is another small step on my dividend income journey to 10 000 EUR. which I want to reach until I am 40 years old. So the next stop is 2 500 EUR :)…

The current average dividend income per month is now at 190.86 EUR, which is a nice monthly addition considering the fact that I do not have to work for that :).

In 2019 my main goal is to keep an eye on my 5 stocks to add list, and to concentrate on stocks with a low debt to equity ratio and high equity ratios. Any potential upcoming investments are Prudential Financial, Valero Energy and Uniqa Insurance.

Keep on investing guys!!

What do you think about the my investments? Anything in common on your side?

Disclosure: I do not recommend any decision to the reader or any user, please consult your own research. Thank you for your understanding!

Be the first to comment

Leave a Reply

Your email address will not be published.